PUBLISHER: Grand View Research | PRODUCT CODE: 1511924
PUBLISHER: Grand View Research | PRODUCT CODE: 1511924
The global ambulatory surgery centers market is anticipated to reach USD 205.52 billion by 2030 and is anticipated to expand at a CAGR of 6.25% during the forecast period, according to a new report by Grand View Research, Inc. An increase in the number of surgeries, the increase in shift of surgical procedures from hospitals to ambulatory centers, and the rise in cost of hospitals led to demand for ambulatory services is expected to fuel the market expansion.
The number of patient admissions is slowly decreasing in hospitals, owing to increasing outpatient visits. This is primarily due to high hospitalization costs and the adoption of technologically advanced methods in outpatient centers, making treatments fast and cost-effective. Changes in reimbursement policies have also increased the number of people opting for a diagnostic test in nearby community ambulatory care units compared to city hospitals.
Furthermore, non-invasive procedures and minimally invasive surgeries supported by technological advancements have reduced the duration of hospital stays, reducing healthcare expenditure. For instance, endoscopy and laparoscopic technology development has reduced the need for hospital admissions. According to the Endosound in 2022, around 30 million surgeries and procedures are conducted each year at 5,800 ASCs in the U.S.
Key participants are engaged in different strategies to expand their global footprint through innovations, partnership collaborations, and product launches. For instance, in January 2024, TPG, a global asset management firm, announced its strategic investment in Compass Surgical Partners. The purpose of this investment is to speed up development and increase capacity in response to the growing demand for ASC joint ventures from health system partners.